This market’s expansion is primarily fueled by the rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, which necessitate frequent surgical interventions. For example, the International Diabetes Federation reported that there were approximately 537 million people with diabetes in 2021, a number expected to rise to 643 million by 2030, directly increasing the demand for surgical sutures. A key trend driving growth is the shift toward minimally invasive surgeries, which have seen an increase of over 30% in the last five years. This trend, coupled with advancements in suture technology, including the use of biocompatible materials, is broadening the market's scope.

Absorbable sutures are a major component of this market, with their value projected to grow from USD 1.55 billion in 2024 to USD 2.2 billion by 2035. Their popularity is due to their ability to support wounds until they heal and then naturally degrade, reducing the need for follow-up procedures. The market is also seeing a focus on innovation, with the development of "smart" sutures that can monitor wound healing or deliver therapeutic agents.

Regionally, North America holds the largest market share, with a projected value of USD 1.45 billion in 2024, expected to grow to USD 2.05 billion by 2035. This dominance is attributed to a high frequency of surgical operations and robust healthcare expenditure in the region. Other key applications for surgical sutures include cardiothoracic surgery, which is essential due to the prevalence of cardiovascular diseases, and orthopedic surgery, driven by an increase in sports-related injuries. End-users are primarily hospitals, which dominate the landscape due to their advanced surgical facilities and high volume of complex procedures.

Other Related Reports from Market Research Future (MRFR)

China Car T Cell Therapy Market

US Formulation Development Outsourcing Market

US Growth Hormone Deficiency Market